Ingela Hallberg

Part of Otsuka Holdings Co., Ltd., Otsuka Pharma Scandinavia AB is a pharmaceutical and nutraceutical company based in Stockholm, SE. Otsuka Pharma Scandinavia aims to improve the health of patients by focusing on some of the world's unresolved health issues and creating solutions and opportunities for some of the most challenging conditions of the body and mind. Otsuka Pharma Scandinavia is dedicated to making a difference for patients in their daily lives and focuses on getting the job done together as a team, guided by its values of integrity, compassion, excellence, creativity, and collaboration. The Swedish company is committed to conducting business ethically and in compliance with the laws and regulations of the countries where it operates. The company invests substantially in research and development in both common and rare conditions, with a network of 44 research institutes around the world.

Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.

IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden.

H. Lundbeck AB operates as a pharmaceutical company specializing in psychiatric and neurological disorders. It offers a broad range of products within brain diseases such as depression, schizophrenia, Alzheimer, and Parkinson. The company is headquartered in Malmo, Sweden.